Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCVax-Prostate in metastatic hormone refractory prostate cancer
NCT00043212Phase 3Withdrawn
- Sponsor
- Northwest Biotherapeutics
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prostate cancer (PCa) comparing DCVax-Prostate with Placebo (2 arms). Status: withdrawn.
02
Drugs
DCVax-Prostate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00043212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043212.